Skip to main content

Table 3 SNCG Expression in Metastases of Primary Tumors

From: Synuclein-γ (SNCG) expression in ovarian cancer is associated with high-risk clinicopathologic disease

Primary/Metastasis

N

N event

Median OS (months)

2 years OS

5 years OS

−/+ (Gained expression)

12

10

47 (30,102)

91.67 %

41.67 %

+/− (Lost expression)

34

26

32 (17,55)

58.82 %

32.09 %

+/+ (Maintained expression)

118

104

39 (27,44)

65.25 %

20.59 %

−/− (Never expressed)

19

17

17 (9,44)

47.37 %

21.05 %

Log-rank p = 0.23

Combined Metastatic Expression

Positive

130

114

40 (29,44)

67.69 %

22.65 %

Negative

53

43

29 (15,44)

54.72 %

28.18 %